Forty-seven (36%) had major clinical contraindication to treatment (i.e. mental illness, cirrhosis, cardiac disease, low CD4+ cell count in HIV+ subjects), 18 (13%) refused the treatment, 7 (5%) moved to other Institute and 27 (20%) were not evaluated by infectious disease specialist. The gene discussed is CD4; the disease is psychiatric disorder.